Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy.
Multiple Sclerosis International Federation: Stimulating international cooperation in research.
Examination of Cognitive Fatigue in Multiple Sclerosis using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging.
Are there evidence-based dietary interventions for multiple sclerosis?
Th1-mediated experimental autoimmune encephalomyelitis is CXCR3-independent.
Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis.
Neuro-ophthalmology update.
Vitamin d and long-term memory in multiple sclerosis.
Coexistence of Guillain-Barré syndrome and Behçet's disease.
Opexa Therapeutics reports third quarter 2013 financial results and provides corporate update
Discovery of novel disease-specific and membrane-associated markers in a mouse model of multiple sclerosis.
Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial.
Drugs that Treat Skin Conditions May Help Combat Multiple Sclerosis.
Central Autonomic Dysfunction Delays Recovery of Fingolimod Induced Heart Rate Slowing.
Nicotinic receptor activation negatively modulates pro-inflammatory cytokine production in multiple sclerosis patients.
Bilateral hypogeusia caused by a small lesion in the lower midbrain tegmentum.
Translation and Cultural Adaptation of the Multidimensional Scale of Perceived Social Support for Greece.
Multiple sclerosis: Could simvastatin slow down secondary progressive MS?
Do textured insoles effect postural control and spatiotemporal parameters of gait and plantar sensation in people with multiple sclerosis?
Tiliroside, a dietary glycosidic flavonoid, inhibits TRAF-6/NF-κB/p38-mediated neuroinflammation in activated BV2 microglia.
Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.
Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.
The Gap in the Current Research on the Link between Health Locus of Control and Multiple Sclerosis: Lessons and Insights from a Systematic Review.
The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis.
Managed care aspects of managing multiple sclerosis.
Pages
« first
‹ previous
…
424
425
426
427
428
429
430
431
432
…
next ›
last »